Literature DB >> 3304711

Immunochemiluminometric assay of creatine kinase MB with a monoclonal antibody to the MB isoenzyme.

U Piran, D W Kohn, L S Uretsky, D Bernier, E H Barlow, C A Niswander, M Stastny.   

Abstract

Previous two-site immunometric assays for creatine kinase (CK; EC 2.7.3.2) MB isoenzyme have been based on formation of a "sandwich" complex involving CK-MB and antibodies that recognize the CK-MM and the CK-BB isoenzymes. Single-incubation model assays of CK-MB with these antibodies were susceptible to interferences by CK-MM and CK-BB. We produced two anti-CK-MB monoclonal antibodies and studied their suitability for two-site assays. Both antibodies were compatible with anti-CK-MM and anti-CK-BB, but not with each other. Using anti-CK-MB as the tracer antibody eliminated the interference by both CK-MM and CK-BB. Labeling anti-CK-MB with acridinium ester and immobilizing anti-CK-BB on paramagnetic particles, we developed a rapid and highly sensitive chemiluminescent/magnetic separation CK-MB assay. As little as 1 microgram of CK-MB per liter was detectable after 10- or 30-min incubation at room temperature, and the standard curve was linear up to 400 micrograms/L. Results for serum samples by the new assay correlated well (r = 0.94) with those by Corning electrophoretic and the Hybritech Tandem-E immunoenzymometric CK-MB methods. Sera containing macro CK-1 or high concentrations of CK-MM and CK-BB did not interfere. The combined advantages of a more-specific antibody, paramagnetic solid phase, and chemiluminescent label endow this two-site CK-MB assay with performance characteristics and ease of use superior to those of previous assays.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304711

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Monoclonal antibodies for clinical applications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1988-12       Impact factor: 2.926

2.  Left ventricular diastolic function of the reperfused postischemic donor heart.

Authors:  T Shirai; M Sunamori; A Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure.

Authors:  T Goto; H Takase; T Toriyama; T Sugiura; K Sato; R Ueda; Y Dohi
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

4.  Creatine kinase isoenzymes in the diagnosis of intestinal infarction.

Authors:  M W Fried; U K Murthy; S R Hassig; J Woo; R P Oates
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

5.  The effect of betamethasone on myocardial viability during cold cardioplegia in canine donor heart preservation.

Authors:  H Miyamoto; M Sunamori; T Yoshida; A Suzuki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Effect of the addition of albumin to crystalloid cardioplegic solutions on myocardial metabolism in infants undergoing open heart surgery.

Authors:  K Hisatomi; T Isomura; N Hayashida; T Sato; K Kosuga; S Aoyagi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

7.  Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).

Authors:  Norifumi Kawakita; Kentaro Ejiri; Toru Miyoshi; Kunihisa Kohno; Makoto Nakahama; Masayuki Doi; Mitsuru Munemasa; Masaaki Murakami; Kazufumi Nakamura; Hiroshi Ito
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

Review 8.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.